Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Germany · Delayed Price · Currency is EUR

2.620

-0.020 (-0.76%)

At close: Jun 26, 2026

-11.19% (1Y)

Market Cap	219.00M -11.8%
Revenue (ttm)	335.01M -2.3%
Net Income	4.42M -59.0%
EPS	0.05
Shares Out	n/a
PE Ratio	49.60
Forward PE	13.11
Dividend	0.02 (0.74%)
Ex-Dividend Date	May 21, 2026

Volume	n/a
Open	2.630
Previous Close	2.640
Day's Range	2.620 - 2.630
52-Week Range	2.130 - 3.190
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1929

Employees 1,400

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol FEQ1

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Financial Statements